CBS Evening News for Friday, May 19, 2000
View other clips in this broadcast →
Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.
(Studio: Dan Rather) Report introduced.
(Washington: Sharyl Attkisson) The FDA's defense of keeping the diabetes drug Rezulin on the market in spite of safety concerns reported. [FDA (Food and Drug Administration) Dr. Murray LUMPKIN - comments.] [Warner-Lambert/Parke Davis Peter CORR - says the media information was inaccurate.] [FDA (Food and Drug Administration) medical reviewer Dr. Robert MISBIN - says he was not asked to speak.]
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.